Motilal Oswal’s private equity arm has agreed to invest up to Rs 460 crore ($53 million) for a majority stake in Megafine Pharma, an export-focused Active Pharmaceutical Ingredients (API) company, according to an announcement.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
